MedTrace Logo

Haloperidol vs. Valproate in Agitation

NCT01750541 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2013-01-08

No results posted yet for this study

Summary

The aim of this study is to compare the efficacy of haloperidol and valproate in management of people with agitation in emergency department

Conditions

  • Psychomotor Agitation

Interventions

DRUG

Haloperidol

DRUG

Valproate

Sponsors & Collaborators

  • Shahid Beheshti University of Medical Sciences

    lead OTHER

Principal Investigators

  • Kamran Heydari, MD · Department of Emergency Medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2012-12-31
Completion
2013-01-31

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01750541 on ClinicalTrials.gov